Roy Baynes Sells 32,750 Shares of Travere Therapeutics (NASDAQ:TVTX) Stock
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) Director Roy Baynes sold 32,750 shares of the stock in a transaction dated Tuesday, April 14th. The stock was sold at an average price of $41.29, for a total value of $1,352,247.50. Following the sale, the director directly owned 37,500 shares in the company, valued at $1,548,375. […]
18 Apr 08:40 · The Markets Daily